References
- Adamson JW, Eschbach JW, Finch CA. The kidney and erythropoiesis. Am J Med 1968;44:725-33.
- Bommer J, Alexiou C, Muiler-Buhl U, Eifert J, Ritz E. Recombinant human erythropoietin therapy in haemodialysis patients—dose determination and clinical experience. Nephrology Dialysis Transplantation 1987;2:238-42.
- Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of combined Phase 1 and II clinical trial. N Engl J Med 1987;316:73-8.
- Eschbach JW, Adamson JW. Correction of the anemia of hemodialysis (HD) patients with recombinant human erythropoietin (r-HuEpo): results of a multicenter study (abstract). Kidney International l988;33:l89.
- Eschbach JW, Kelly MR, Haley NR, Abels RI, Adamson JW. Treatment of the anemia of progressive renal failure with recombinant human erythropoietin. N Engl J Med 1989: 321:158-63.
- Winearis CG, Oliver DO. P?ppard MJ, Reid. C, Downing MR, Cotes PM. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet l986;2:l 175-8.
- Kokot F. Wiecek A, Grzeszcak W. Decreased need for blood transfusion during one year after discontinued erythropoietin treatment in haemodialyzed patients. Nephron 1991;58:246-7.
- D’Agostino RB. An omnibus test for normality of moderate and large samples. Biometnika 1971:58:341 -8.
- Zar JH. Biostatistical analysis. New York: Prentice Hall, 1984:190-3;228-31.
- Consensus Conference. Perioperative red cell transfusion. JAMA 1988;260:2700-3.
- Stehling L, Simon TL. The red blood cell transfusion trigger. Physiology and clinical studies. Arch Pathol Lab Med 1994; 118:429-34.
- Spence RK, Carson JA, Poses R, et al. Elective surgery without transfusion: influence of preoperative hemoglobin level and blood loss on mortality. Am J Surg 1990; 159:320-4.